Patent · US Active

Process for preparation of triaminopyrimidine compound and intermediates thereof

US12378223B2 · kind B2 · utility

0Cited by

0References

25Claims

0Family size

Assignee

Zydus Lifesciences Limited · IN

Inventors

Kumar Kamlesh SINGH · Sayla, IN
Nikhil Amar Singh · Gandhinagar, IN
Ganapatdan Shimbhu Charan · Gandhinagar, IN
Nimeshkumar Mukeshkumar Shah · Sayla, IN
Sunil Dnyaneshwar Narode · Sayla, IN
Dipakkumar Dhanjibhai Vachhani · Gandhinagar, IN
Amol Kashinath Patil · Gandhinagar, IN
Sandip Pundlik Khairnar · Gandhinagar, IN

Key dates

Filing date	Sep 4, 2018
Grant date	Aug 5, 2025
Priority date	—
Expiry date	Dec 21, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to triaminopyrimidine compound 1, or pharmaceutically acceptable salts thereof, or hydrates, or solvates, or polymorphs, or optically active forms thereof, in solid state forms. The invention also relates to a process for preparation of triaminopyrimidine compound and intermediates thereof. The present invention also relates to a pharmaceutical composition comprising pure triaminopyrimidine compound, useful for preventing or treating malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.